What You Should Know:
- Today Medidata, a Dassault Systèmes company, launched myMedidata Registries – a new technology that expands and strengthens the company’s myMedidata patient portal to engage patients before and after (i.e., long term follow-up/safety surveillance) a clinical trial.
- The offering, which redefines Medidata’s end-to-end technology solutions and represents a major advance for the life sciences industry, empowers patients to
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
PE Firm Thoma Bravo Acquires Clinical Trial Financial Platform Greenphire – Health M&A
What You Should Know:
- Thoma Bravo, a private equity investment firm focused on the software and technology-enabled services sector announced that it has reached an agreement to acquire Greenphire, a financial lifecycle management software for clinical trials, from The Riverside Company. Financial details were not disclosed for the pending transaction.
- The acquisition, which is subject to customary regulatory approvals, is expected to close in the second quarter of this year.
-
Read More
Florence Raises $80M to Expand Connectivity Platform for Clinical Trials
What You Should Know:
- Florence, a site connectivity platform in clinical trials, today announced the close of a $80 million Series C funding round led by Insight Partners, a global venture capital and private equity firm focused on investing in ScaleUp software companies. Existing investors Fulcrum Equity Partners, Bee Partners, and Flashpoint also joined this round.
- Based in Atlanta, GA, Florence is a global leader in remote connectivity and electronic document workflow management for
Read More
Cancer Centers: Here’s How We Can Restart Clinical Trials Today
Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More
DoD, Duke, John Hopkins, HJF, physIQ Launch 18-Month COVID-19 Clinical Trial Study
What You Should Know:
- Today, PhysIQ Inc. announced its partnership with Johns Hopkins University, Duke University and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), to support a clinical trial to evaluate products for early treatment and post-exposure treatment of COVID-19. The 18-month study will assess disease progression and provide early indication of infection. This DOD-funded initiative will assess the role of continuous biosensor
Read More
Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices
What You Should Know:
- Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research.
- SiteBridge Research creates a network of independent, small practice physicians to gather data from a broader, more inclusive patient population and, ultimately, create more widely applicable clinical
Read More
Syneos, Medable Team Up to Bring Decentralized Clinical Trials to Patients
What You Should Know:
- Syneos Health, a fully integrated biopharmaceutical solutions organization, and Medable, a cloud platform for patient-centered drug development, announced a strategic partnership to bring clinical trials closer to the patient.
- The partnership will deliver new decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while improving patient access and experiences to transform biopharmaceutical product development.
- As part
Read More
Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development
What You Should Know:
- Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc., and Streamlined Ventures.
- This is
Read More
Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an estimated 80% of non-COVID-19 trials—came to a halt or were interrupted by the pandemic, which challenged the ability to conduct trials safely and effectively and was complicated by the reality that trials often deal with the populations most at risk from COVID-19 exposure1.
In response, clinical researchers turned to a range of
Read More
Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching
What You Should Know:
- Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardinal network. VIPER will be a part of Cardinal Health’s new Navista advanced suite of technology solutions designed to help oncologists improve outcomes, provide high quality care at the best possible cost and select the right care plan at the onset of
Read More
